Second Annual Joint Symposium on:
Biomarkers and Drug Development and Bioanalytical Issues
at
Presents
on
Thursday, March 8th, 2012
Second Annual Joint Symposium on:
Biomarkers and Drug Development and Bioanalytical Issues
at
Sheraton Bucks County, Langhorne, PA
Current Agenda
Faraz Kazmi, Senior Scientist, Research & Innovation, XenoTech LLC "An in vitro method to investigate drug-drug interactions with biologics"
CNS Biomarkers: A Comparison of GC/MS/MS and LC/MS/MS Techniques
Alan P. Breau, Vice President, MPI Research: "Mining the Neurotransmitter Metabolome Using GC/MS/MS"
Michael P Sullivan, Senior Research Fellow, Worldwide Clinical Trials "Small Molecule Biomarker LC/MS/MS Analysis: Neurotransmitters for CNS Studies"
Dominique Gouty, Senior Director at Intertek/ALTA Immunochemistry "Effect of Anticoagulant on Biomarker Assay Performance"
Ryan J. Wenzel, Director of N.A. Operations, CovalX Instruments Inc., "Direct analysis of protein-protein interactions from biological complexes or biopharmaceutical aggregates"
Mark Wrona, Senior Scientist, Waters Corporation "Data Requirements in the DMPK Process - What to Collect and When"
Attendance at this meeting is free of charge thanks to the following Sponsors:
BD Biosciences, Celsis, GigaCyte, Intertek/ALTA, MPI Research, QPS, Scynexis, Shimadzu/ CovalX Instruments Inc., Tandem LabCorp, Waters, Worldwide Clinical Trials, Xenotech
Advance Registration must made before Sunday, March 4, 2012
